Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05224466
Other study ID # PD
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date March 2022
Est. completion date December 2024

Study information

Verified date February 2022
Source Shanghai Jiao Tong University School of Medicine
Contact Na Jiang, MD
Phone +86-21-53882014
Email Jiangjiang198311@163.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Peritoneal dialysis patients worldwide account for about 11% of the global dialysis population. The global annual growth rate of peritoneal dialysis is estimated to be 8%, which is listed as the preferred method of renal replacement therapy in most countries. Although peritoneal dialysis has been widely used, due to complications such as peritoneal dialysis related infection, peritoneal ultrafiltration failure and EPS, the failure rate of peritoneal dialysis technology is high, and the 3-year technical survival rate is only 64%. Therefore, this study intends to explore clinical strategies for maintaining the long-term peritoneal dialysis by analyzing the clinical characteristics of patients , as well as the differences of risk factors affecting the survival rate of peritoneal dialysis technology at different time stages of peritoneal dialysis treatment.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 400
Est. completion date December 2024
Est. primary completion date December 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - ESRD patients - The first time of peritoneal dialysis Exclusion Criteria: - Age <18 years at start of PD - Transfer or follow-up loss - Previous transplantation or HD history - Incomplete clinical data

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
China Shanghai Renji Hospital, Shanghai Jiaotong University School of Medicine Shanghai Shanghai

Sponsors (1)

Lead Sponsor Collaborator
Shanghai Jiao Tong University School of Medicine

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary baseline clinical characteristics before PD clinical characteristics about age,sex,comorbidities before PD,laboratory data would be aggregated from the existing record to find out the differences between the long-term PD patients and the others that may affect their clinical outcome. within one month before the start of PD
Secondary the factors that may lead to the termination of PD Some patients may end the PD early ,some late due to many reasons.To find out the factors that may influence survival rate of peritoneal dialysis technology at different time stages of peritoneal dialysis treatment, the investigators collect and record the reasons for termination of PD to analyze. up to 20 years
See also
  Status Clinical Trial Phase
Not yet recruiting NCT04034628 - Improving the Outcomes of Peritoneal Dialysis (PD) Catheter Insertion
Completed NCT03569410 - The Effect of Natural Protein vs. Protein Supplements on Peritoneal Dialysis Patients N/A
Completed NCT04302649 - Dialysate Temperature in Peritoneal Dialysis Phase 4
Enrolling by invitation NCT05250752 - Reduction of Peritoneal Glucose Uptake With Use of SGLT2 in Humans Undergoing Peritoneal Dialysis Treatment Phase 2
Recruiting NCT03563898 - Feasibility and Safety in the Management of Fluid Overload in Peritoneal Dialysis Patients Through Sweat Stimulation With the Use of Portable Sauna Bath, Pilot Study N/A
Recruiting NCT03046511 - Peritonitis Prevention After Insertion of Peritoneal Dialysis Catheter. Phase 3
Completed NCT03458819 - EMT in Peritoneal Dialysis Patients
Recruiting NCT06398977 - Dapagliflozin Delays the Loss of Renal Function in Peritoneal Dialysis Patients N/A
Not yet recruiting NCT06045858 - SAFETY AND EFFICACY OF APIXABAN VERSUS WARFARIN IN PERITONEAL DIALYSIS PATIENTS WITH NON VALVULAR ATRIAL FIBRILLATION: A PROSPECTIVE, RANDOMISED, OPEN-LABEL, BLINDED END-POINT TRIAL (APIDP2) Phase 3
Active, not recruiting NCT04034966 - Utility of Telemedicine in the Follow-Up of Patients in Peritoneal Dialysis N/A
Completed NCT04923295 - The Effect of Dapagliflozin on Ultrafiltration Among Peritoneal Dialysis Patients N/A
Not yet recruiting NCT05715814 - meChANisms and sAfety of SGLT2 Inhibition in peRitoneal dialYsis Phase 3
Recruiting NCT03148002 - Peritoneal Dialysis Pilot Study: Evaluating Polyethylene Glycol (PEG) for Constipation Phase 4
Recruiting NCT04572724 - The Effect of Sacubitril/Valsartan on Cardiovascular Events in Dialysis Patients and Efficacy Prediction of Baseline LVEF Value Phase 4
Completed NCT05797181 - The Effect Of Medical Nutritional Therapy On Patients With Sarcopenic Obesity Receiving Peritoneal Dialysis Treatment N/A
Recruiting NCT01893710 - International (Pediatric) Peritoneal Biobank
Completed NCT03382444 - The Kidney and The Brain Study - Assessment of Cognitive Impairment in Advanced CKD
Completed NCT04046263 - Effect of Velphoro on Serum Phosphate and Albumin in Peritoneal Dialysis Patients Phase 4
Completed NCT03759002 - Association of Mean Platelet Volume and Cardiovascular Disease in Children With End Stage Renal Disease.
Completed NCT04176627 - Assessing Fluid Status of Peritoneal Dialysis Patients With Assistance of Lung Ultrasound